COVID-19 Key EU Developments, Policy & Regulatory Update No. 56

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
This regular update (no. 56 | 19 July 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices...
European Union Coronavirus (COVID-19)
To print this article, all you need is to be registered or login on Mondaq.com.

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

LATEST KEY DEVELOPMENTS

Competition & State Aid

  • European Commission re-approves €1.2 billion rescue loan to TAP Air Portugal
  • European Commission adopts positive assessments of Recovery and Resilience Plans from an additional 2 Member States
  • European Commission approves new and amended Member State measures to support the economy

Trade / Export Controls

  • Slovenian Presidency of the Council of the EU to propose WTO-level negotiations for temporary suspension of vaccine patents

Medicines and Medical Devices

  • No noteworthy developments for this issue

Cybersecurity, Privacy & Data Protection

  • ENISA hosts Workshop on remote identity proofing

To view the full article, please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More